Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Tugce Ozgen"'
Autor:
Katherine Klein, Kewen He, Ahmed I. Younes, Hampartsoum B. Barsoumian, Dawei Chen, Tugce Ozgen, Sara Mosaffa, Roshal R. Patel, Meidi Gu, Jose Novaes, Aarthi Narayanan, Maria Angelica Cortez, James W. Welsh
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The role of mitochondria in cancer formation and progression has been studied extensively, but much remains to be understood about this complex relationship. Mitochondria regulate many processes that are known to be altered in cancer cells, from meta
Externí odkaz:
https://doaj.org/article/3d3575ff14284a47b2bbc868d0a42c50
Autor:
Ekici, Ahmet1 (AUTHOR) ekici@bilkent.edu.tr, Genc, Tugce Ozgen1 (AUTHOR), Celik, Hafize1 (AUTHOR)
Publikováno v:
Journal of Macromarketing. Mar2021, Vol. 41 Issue 1, p25-47. 23p.
Autor:
James W. Welsh, Maria Angelica Cortez, Katherine Klein, Tugce Ozgen, Sara Mosaffa, Fatemeh Masropour, Mark Wasley, Hari Menon, Yun Hu, Vivek Verma, Ahmed I. Younes, Liangpeng Yang, Hampartsoum B. Barsoumian, Dawei Chen
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f95625e3541384be46a8ffa61c5569c
https://doi.org/10.1158/2326-6066.22543947
https://doi.org/10.1158/2326-6066.22543947
Autor:
James W. Welsh, Maria Angelica Cortez, Katherine Klein, Tugce Ozgen, Sara Mosaffa, Fatemeh Masropour, Mark Wasley, Hari Menon, Yun Hu, Vivek Verma, Ahmed I. Younes, Liangpeng Yang, Hampartsoum B. Barsoumian, Dawei Chen
Immune checkpoint inhibitors, such as anti–PD-1/PD-L1, have emerged as promising therapies for advanced non–small cell lung cancer (NSCLC). However, approximately 80% of patients do not respond to immunotherapy given alone because of intrinsic or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda51812534a46937fc87a65c71cbc67
https://doi.org/10.1158/2326-6066.c.6550473
https://doi.org/10.1158/2326-6066.c.6550473
Autor:
Tugce Ozgen Genc, Ahmet Ekici
Publikováno v:
Sustainable Production and Consumption
Food waste generated at the household level is known to be the main contributor to total food waste, particularly in developed regions. Reducing household food waste (HFW), however, is an extremely compelling task as there are many complex and intera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107b57d081fdc1a9f899e37c53a813e3
https://hdl.handle.net/11693/111401
https://hdl.handle.net/11693/111401
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Macromarketing
In their essays published in the Silver Anniversary Issue (SAI) of the Journal of Macromarketing (2006), George Fisk and Mark Peterson independently outlined the current state of the discipline and made a list of visionary recommendations that would
Autor:
Yun Hu, Maria Angelica Cortez, Sara Mosaffa, Mark Wasley, Hari Menon, Ahmed I. Younes, Tugce Ozgen, Hampartsoum B. Barsoumian, Fatemeh Masropour, L. Yang, Vivek Verma, James W. Welsh, Dawei Chen, Katherine Klein
Publikováno v:
Cancer Immunol Res
Immune checkpoint inhibitors, such as anti–PD-1/PD-L1, have emerged as promising therapies for advanced non–small cell lung cancer (NSCLC). However, approximately 80% of patients do not respond to immunotherapy given alone because of intrinsic or
Autor:
Bonnie S. Glisson, Joe Y. Chang, Vassiliki A. Papadimitrakopoulou, John V. Heymach, Katherine Klein, George R. Simon, Vivek Verma, James W. Welsh, Roshal R. Patel, Jianjun Zhang, Ferdinandos Skoulidis, Chunxiao Guo, Taylor R. Cushman, Quynh Nhu Nguyen, Mehmet Altan, Tugce Ozgen, Hari Menon, Girish S. Shroff, Lauren Averett Byers, Dawei Chen, Nathan Comeaux, Chad Tang, Melenda Jeter, Kenneth R. Hess
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 15(12)
Introduction Few advancements in treating limited-stage SCLC (LS-SCLC) have been made in decades. We report here a phase 1/2 trial of concurrent chemoradiotherapy (CRT) and pembrolizumab. Methods This single-center, open-label phase 1/2 study recruit
This study explores whether and how people with a negative biotechnology-related perception can change their attitudes when they are exposed to a positive message in two different frames. The two frames differ in terms of the medium, the language use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4483::506d83b048d7d91a0536f4ee8aee09e5
http://hdl.handle.net/20.500.11851/1613
http://hdl.handle.net/20.500.11851/1613